Steroid-resistant
Difference of Vitamin D and Interleukin-6 Levels in Children with Steroid- Resistant, Steroid-Sensitive and Idiopathic Nephrotic Syndrome
10
Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry and multivariate statistical analysis
10
Steroid resistant asthma Cellular mechanisms contributing to inadequate response to glucocorticoid therapy
8
Treatment Strategies for Childhood Steroid- Resistant Nephrotic Syndrome
13
Cellular mechanisms underlying steroid-resistant asthma
10
Flow cytometry analysis of glucocorticoid receptor expression and binding in steroid sensitive and steroid resistant patients with systemic lupus erythematosus
11
Relative safety of steroid sparing agents in frequently relapsing, steroid dependent and steroid resistant nephrotic syndrome in pediatric patients
5
Cyclosporine A and steroid therapy in childhood steroid-resistant nephrotic syndrome
5
NPHS2 Gene Mutation and Polymorphisms in Indonesian Children with Steroid Resistant Nephrotic Syndrome
8
A 17-Year-Old With Steroid-Resistant Nephrotic Syndrome
7
Advillin acts upstream of phospholipase C ϵ1 in steroid resistant nephrotic syndrome
14
Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis
8
Steroid-resistant nephrotic syndrome: past and current perspectives
9
Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome
10
Azathioprine therapy for steroid-resistant Henoch-Schönlein purpura: a report of 6 cases
7
Haemophilus influenzae induces steroid-resistant inflammatory responses in COPD
8
Relationship of Childhood Idiopathic Nephrotic Syndrome with Asthma, Hypertension, Complement C3, Urinalysis
5
Level Of 25(OH)D Serum, Expression of Interleukin 4 And Glucocorticoid Receptor of Mononuclear Cell In Steroid Resistance Nephrotic Syndrome Children
6
Evidence-based guideline update: Plasmapheresis in neurologic disordersReport of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
8
Abstract
6